Live Breaking News & Updates on Hisun Pharma|Page 2

Global Biosimilar Monoclonal Antibodies Market Report 2020-2030: COVID-19 Impact, Growth and Changes
ResearchAndMarkets.com s offering.
Biosimilar Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar monoclonal antibodies market.
Major players in the biosimilar monoclonal antibodies market are Pfizer, Novartis, Allergan, Coherus BioSciences, Biocon, Amgen, Boehringer Ingelheim, Celltrion, BioXpress Therapeutics, and Intas Pharmaceuticals Limited.
The global biosimilar monoclonal antibodies market is expected to decline from $3.21 billion in 2019 to $3.04 billion in 2020 at a compound annual growth rate (CAGR) of -5.18%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other comme ....

United States , Coherus Biosciences , Hisun Pharma , Celgen Biopharma , Laura Wood , Reliance Life Sciences , Boehringer Ingelheim , Custom Research , Torrent Pharmaceuticals , Office Hours Call , Genor Biopharma Co , Drug Administration , E St Office Hours Call , Intas Pharmaceuticals , Reddys Laboratories Ltd , Aurobindo Pharma , European Medicines Agency , Monoclonal Antibodies Global Market Report , Bioxpress Therapeutics , Aurobindo Pharma Limited , Topics Covered , Monoclonal Antibodies Market Characteristics , Monoclonal Antibodies Market Size And Growth , Biosimilar Monoclonal Antibodies Historic Market , The Market , Biosimilar Monoclonal Antibodies Forecast Market ,